Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2001 2
2002 2
2003 5
2004 4
2005 17
2006 21
2007 22
2008 16
2009 9
2010 12
2011 9
2012 12
2013 8
2014 10
2015 6
2016 12
2017 6
2018 1
2019 2
2020 9
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

172 results
Results by year
Filters applied: . Clear all
Page 1
Local and systemic safety of intranasal corticosteroids.
Sastre J, Mosges R. Sastre J, et al. J Investig Allergol Clin Immunol. 2012;22(1):1-12. J Investig Allergol Clin Immunol. 2012. PMID: 22448448 Free article. Review.
Nonetheless, concerns remain among some prescribers and patients that these agents may reach the systemic circulation in sufficient concentration to produce adverse effects (AEs). Available evidence does not support these concerns. A review of the published literatu …
Nonetheless, concerns remain among some prescribers and patients that these agents may reach the systemic circulation in sufficient concentr …
Ciclesonide and the treatment of asthma.
Korenblat PE. Korenblat PE. Expert Opin Pharmacother. 2010 Feb;11(3):463-79. doi: 10.1517/14656560903575647. Expert Opin Pharmacother. 2010. PMID: 20102309 Review.
This and other pharmacodynamic and pharmacokinetic properties may limit the amount of active molecule outside the lung and may reduce the incidence of side effects. Randomized placebo-controlled studies found that ciclesonide can initiate and maintain disease contro …
This and other pharmacodynamic and pharmacokinetic properties may limit the amount of active molecule outside the lung and may reduce the in …
Ciclesonide versus other inhaled steroids for chronic asthma in children and adults.
Manning P, Gibson PG, Lasserson TJ. Manning P, et al. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD007031. doi: 10.1002/14651858.CD007031. Cochrane Database Syst Rev. 2008. PMID: 18425977 Review.
OBJECTIVES: To assess the efficacy and adverse effects of ciclesonide relative to those of other inhaled corticosteroids in the management of chronic asthma. ...Paediatric quality of life scores did not differ between treatments. Adverse events occurre …
OBJECTIVES: To assess the efficacy and adverse effects of ciclesonide relative to those of other inhaled corticosteroid …
The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide.
Meltzer EO, Derendorf H. Meltzer EO, et al. Ann Allergy Asthma Immunol. 2006 Aug;97(2):149-57. doi: 10.1016/S1081-1206(10)60005-1. Ann Allergy Asthma Immunol. 2006. PMID: 16937743 Review.
OBJECTIVE: To review the potential systemic activity of ciclesonide and its active metabolite, desisobutyryl-ciclesonide, by evaluation of the effects on hypothalamic-pituitary-adrenal (HPA) axis function. DATA SOURCES: EMBASE and MEDLINE searches using the k …
OBJECTIVE: To review the potential systemic activity of ciclesonide and its active metabolite, desisobutyryl-ciclesonide, by e …
Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
Kramer S, Rottier BL, Scholten RJ, Boluyt N. Kramer S, et al. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD010352. doi: 10.1002/14651858.CD010352. Cochrane Database Syst Rev. 2013. PMID: 23450613 Free article. Review.
It can be inhaled once daily, thereby possibly improving adherence. OBJECTIVES: To assess the efficacy and adverse effects of ciclesonide compared to other ICS in the management of chronic asthma in children. ...Two studies were published as conference abstra …
It can be inhaled once daily, thereby possibly improving adherence. OBJECTIVES: To assess the efficacy and adverse effects of …
Different types of intranasal steroids for chronic rhinosinusitis.
Chong LY, Head K, Hopkins C, Philpott C, Burton MJ, Schilder AG. Chong LY, et al. Cochrane Database Syst Rev. 2016 Apr 26;4:CD011993. doi: 10.1002/14651858.CD011993.pub2. Cochrane Database Syst Rev. 2016. PMID: 27115215 Free article. Review.
Our primary outcomes were disease-specific health-related quality of life (HRQL), patient-reported disease severity and the commonest adverse event - epistaxis (nosebleed). Secondary outcomes included general HRQL, endoscopic nasal polyp score, computerised tomography (CT) …
Our primary outcomes were disease-specific health-related quality of life (HRQL), patient-reported disease severity and the commonest adv
Ciclesonide: A Pro-Soft Drug Approach for Mitigation of Side Effects of Inhaled Corticosteroids.
Mukker JK, Singh RSP, Derendorf H. Mukker JK, et al. J Pharm Sci. 2016 Sep;105(9):2509-2514. doi: 10.1016/j.xphs.2016.05.004. Epub 2016 Jun 21. J Pharm Sci. 2016. PMID: 27339407 Review.
However, their long-term use is associated with various oropharyngeal and systemic side and adverse effects. Design of pro-soft drug is one of the strategies, which was adopted in the design of ciclesonide for mitigation of side effects usually observe …
However, their long-term use is associated with various oropharyngeal and systemic side and adverse effects. Design of pro-sof …
Ciclesonide: a review of its use in the management of asthma.
Deeks ED, Perry CM. Deeks ED, et al. Drugs. 2008;68(12):1741-70. doi: 10.2165/00003495-200868120-00010. Drugs. 2008. PMID: 18681495 Review.
The drug is delivered by a non-chlorofluorocarbon hydrofluoroalkane (HFA) metered-dose inhaler (MDI). In the lungs, ciclesonide is converted to an active metabolite, which is responsible for the beneficial effects of the drug in patients with asthma. Ciclesonide
The drug is delivered by a non-chlorofluorocarbon hydrofluoroalkane (HFA) metered-dose inhaler (MDI). In the lungs, ciclesonide is co …
Ciclesonide nasal spray: in allergic rhinitis.
Dhillon S, Wagstaff AJ. Dhillon S, et al. Drugs. 2008;68(6):875-83. doi: 10.2165/00003495-200868060-00009. Drugs. 2008. PMID: 18416590 Review.
Ciclesonide nasal spray delivers the corticosteroid ciclesonide as a hypotonic spray via a metered-dose manual pump. Systemic exposure to ciclesonide and its active metabolite desisobutyryl-ciclesonide is low after intranasal administration. ...
Ciclesonide nasal spray delivers the corticosteroid ciclesonide as a hypotonic spray via a metered-dose manual pump. Systemic
172 results